|
1
|
Caviglia GP, D'Ambrosio R, Colombatto P, Ciancio A. Editorial: PIVKA-II Facilitates Risk Stratification for HCC Following HCV Cure-Authors' Reply. Aliment Pharmacol Ther 2025; 61:585-586. [PMID: 39723756 DOI: 10.1111/apt.18469] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/18/2024] [Revised: 12/18/2024] [Accepted: 12/18/2024] [Indexed: 12/28/2024]
Affiliation(s)
- Gian Paolo Caviglia
- Department of Medical Sciences, Liver Unit, University of Turin, Turin, Italy
| | - Roberta D'Ambrosio
- Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - Piero Colombatto
- Hepatology Unit and Laboratory of Molecular Genetics and Pathology of Hepatitis Viruses, Reference Center of the Tuscany Region for Chronic Liver Disease and Cancer, University Hospital of Pisa, Pisa, Italy
| | - Alessia Ciancio
- Department of Medical Sciences, Liver Unit, University of Turin, Turin, Italy
- Gastroenterology Unit, Città Della Salute e Della Scienza di Torino-Molinette Hospital, Turin, Italy
| |
Collapse
|